DBC Construction is a general contractor with more than 15 years of experience in the biotechnology industry. Founded in 1988, DBC has completed more than 3 million-square-feet of biotech tenant improvements. The company offers a wide variety of services, such as preconstruction, design and build, construction management, laboratory modifications and cGMP manufacturing. Headquartered in San Diego, its clients include Advanced Tissue Sciences, Accumetrics, Acidophil, Agouron Pharmaceuticals, Akamai, Akkadix, Altman Investment Group, Alliance Pharmaceutical, Alexandria Real Estate Equities and Ambit. DBC has also served American Medical Response, American Tri-Tech, American Peptide, AMCC, Amylin Pharmaceuticals, Anady's Pharmaceuticals, Aonix, Applied Computer Solutions, Aqua Investors, Archimedes Technology Group and Arcturus Engineering.